期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

促黄体生成素在卵泡发育及辅助生殖促排卵中的作用 被引量：10

The role of luteotropic hormone in the follicular development and controlled ovarian hyperstimulation in assisted reproduction
暂未订购
导出
摘要 促黄体生成素(luteotropic hormone,LH)对于辅助生殖中诱发排卵或超促排卵具有重要作用,该文就LH在支持卵泡发育中的作用作简单综述。 Luteotropie hormone （LH） has an important role in induced ovulation and controlled ovarian hy- perstimulation in human assisted reproduction. The roles of LH in supporting follicular development were reviewed briefly.
作者 何冰 成俊萍 黄莉 谭毅
机构地区 广西壮族自治区人民医院生殖医学与遗传中心
出处 《中国临床新医学》 2012年第7期656-659,共4页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西卫生厅科研课题(编号:Z2011459) 广西卫生厅重点科研课题(编号:桂卫重2010043)
关键词 辅助生殖 促黄体生成素 卵泡发育 卵母细胞 胚胎 Assisted reproduction Luteotropic hormone （ LH ） Follicular development Oocyte Embryo
分类号 R714.12 [医药卫生—妇产科学]
  • 相关文献

参考文献28

  • 1卢锦,朱艳.卵泡发育及其调节因素的研究进展[J].医学综述,2008,14(4):507-509. 被引量：10
  • 2Balasch J,Fábregues F.Pregnancy after administration of high dose recombinant human LH alone to support final stages of follicular maturation in a woman with long-standing hypogonadotrophic hypogonadism[J].Reprod Biomed Online,2003,6(4):427-431.
  • 3Ferraretti AP,Gianaroli L,Magli MC,et al.Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques[J].Fertil Steril,2004,82(6):1521-1526.
  • 4Filicori M,Cognigni GE.Clinical review 126:Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction[J].J Clin Endocrinol Metab,2001,86(4):1437-1441.
  • 5Shoham Z.The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation[J].Fertil Steril,2002,77(6):1170-1177.
  • 6Lossl K,Andersen AN,Loft A,et al.Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols[J].Hum Reprod,2006,21(10):2593-2600.
  • 7Cavagna M,Maldonado LG,de Souza Bonetti TC,et al.Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression[J].Fertil Steril,2010,94(1):167-172.
  • 8Perin PM,Maluf M,Czeresnia CE,et al.The effect of recombinant human luteinizing hormone on oocyte/embryo quality and treatment outcome in down-regulated women undergoing in vitro fertilization[J].Einstein,2005,3(2):96-105.
  • 9Chung K,Krey L,Katz J,et al.Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists[J].Fertil Steril,2005,84(2):313-318.
  • 10Berkkanoglu M,Isikoglu M,Aydin D,et al.Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders[J].Fertil Steril,2007,88(3):665-669.

二级参考文献19

  • 1沙红英,陈建泉,钱旻,成国祥.哺乳动物卵泡发育的调控机制[J].生殖与避孕,2004,24(5):295-298. 被引量：10
  • 2于淼瑛,周虚.胰岛素在能量影响猪卵泡发育中的作用[J].黑龙江动物繁殖,2005,13(2):12-15. 被引量：3
  • 3苏宁,张清学.卵泡体外培养的研究进展[J].国外医学（计划生育．生殖健康分册）,2006,25(1):24-27. 被引量：4
  • 4Tatemoto H, Sakurai N, Muto N. Protection of porcine oocytes against apoptotic cell death caused by oxidative stress during in vitro maluration: role of cumulus cells[J]. Biol Reprod,2000,63(3) :805-810.
  • 5Louhio H, Hovatta O, Sjoberg J, et al. The effects of insulin, and insulin-like growth factors I and II on human ovarian follicles in long term culture[ J ]. Mol Hum Reprod, 2000,6(8) : 694-698.
  • 6Sekar N, Lavoie HA, Veldhuis JD. Concerted regulation of sleroidogenic acute regulatory gene expression by luteinizing hormone and insulin (or insulin-like growth factor I) in primary cultures of porcine granulosaluteal cells[J]. Endocrinology, 2000,141 ( 11 ) : 3983-3992.
  • 7Thierry Van Dessel HJ,Chandrasekher Y,Yap OW,et al.Serum and follicular fluid levels of insulin-like growth factor I(IGF-Ⅰ),IGF-Ⅱ,and IGF-binding protein-1 and-3 during the normal menstrual cycle [J].Clin Endocrinol Metab,1996,81(3):1224-1231.
  • 8Fournet N, Weitsman SR, Zachow RJ, et al. Transforming growth factor-beta inhibits ovarian 17 alpha-hydroxylase activity by a direct noncompetitive mechanism[ J]. Endocrinology, 1996,137( 1 ) : 166-174.
  • 9Reeka N, Berg FD, Brucker C. Presence of transforming growth factor alpha and epidermal growth factor in human ovarian tissue and follicular fluid[J]. Hum Reprod, 1998, 13(8) :2199-2205.
  • 10Murray JF, Downing JA, Evans G, et al. Epidermal growth factor acts directly on the sheep ovary in vivo to inhibit oestradiol-17 beta and inhibin secretion and enhance progesterone secretion [ J ]. Endocrinol, 1993, 137 ( 2 ) : 253 -264.

共引文献9

同被引文献87

引证文献10

二级引证文献41

中国临床新医学
2012年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部